Pure red cell aplasia and lupus

被引:30
作者
Habib, GS
Saliba, WR
Froom, P
机构
[1] Carmel Hosp, Dept Internal Med B, IL-34362 Haifa, Israel
[2] Tel Aviv Univ, Sackler Sch Med, Dept Epidemiol, Ramat Aviv, Israel
关键词
systemic lupus erythematosus; pure red cell aplasia; clinical features; laboratory findings;
D O I
10.1053/sarh.2002.30440
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To review the clinical and laboratory features of all reported patients with systemic lupus erythematosus (SLE) and pure red cell aplasia (PRCA). Methods: In addition to our patient, we identified cases reported during the years 1966-2000 by searching the MEDLINE literature (Winspirs). Clinical and laboratory features were compared with those reported in large series of patients with SLE but without PRCA. Results: Twenty-three additional cases were identified. In most cases, SLE was diagnosed either before or concomitantly with the diagnosis of PRCA. The clinical and laboratory features were not significantly different from those reported in large series of patients with SLE, except for less pleuritis and a trend toward less proteinuria, hallucinations, thrombopenia, and leukopenia. The natural history of PRCA and SLE was similar to that reported for PRCA alone. The disease responded to prednisone in the majority of cases, but patients frequently remained steroid dependent. Conclusions: The association between SLE and PRCA is rare. The clinical and laboratory features of SLE in such patients are similar to SLE patients without PRCA with the exception of a decreased frequency of pleuritis. Response to treatment of PRCA in those with SLE is similar to patients with PRCA but without SLE. Copyright 2002, Elsevier Science (USA). All rights reserved.
引用
收藏
页码:279 / 283
页数:5
相关论文
共 35 条
  • [1] AACH R, 1968, AM J MED, V44, P90
  • [2] AGUDELO CA, 1988, J RHEUMATOL, V15, P1431
  • [3] ERYTHROID APLASIA IN SYSTEMIC LUPUS ERYTHEMATOSUS
    CASSILETH, PA
    MYERS, AR
    [J]. AMERICAN JOURNAL OF MEDICINE, 1973, 55 (05) : 706 - 710
  • [4] RED-CELL HYPOPLASIA AND INCREASED BONE-MARROW RETICULIN IN SYSTEMIC LUPUS ERYTHEMATOSIS - REVERSAL WITH CORTICOSTEROID-THERAPY
    CAVALCANT, J
    SHADDUCK, RK
    WINKELSTEIN, A
    ZEIGLER, Z
    MENDELOW, H
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 1978, 5 (03) : 253 - 263
  • [5] The T cell enigma in lupus
    Dayal, AK
    Kammer, GM
    [J]. ARTHRITIS AND RHEUMATISM, 1996, 39 (01): : 23 - 33
  • [6] THYMOMA AND PURE RED-CELL APLASIA IN A PATIENT WITH SYSTEMIC LUPUS-ERYTHEMATOSUS
    DUCHMANN, R
    SCHWARTING, A
    PORALLA, T
    ZUMBUSCHENFELDE, KHM
    HERMANN, E
    [J]. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 1995, 24 (04) : 251 - 254
  • [7] Pure red cell aplasia
    Fisch, P
    Handgretinger, R
    Schaefer, HE
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2000, 111 (04) : 1010 - 1022
  • [8] PURE RED-CELL APLASIA - ASSOCIATION WITH SYSTEMIC LUPUS-ERYTHEMATOSUS AND PRIMARY AUTOIMMUNE HYPOTHYROIDISM
    FRANCIS, DA
    [J]. BRITISH MEDICAL JOURNAL, 1982, 284 (6309) : 85 - 85
  • [9] FRANZEN P, 1987, ARTHRITIS RHEUM, V30, P839
  • [10] Fries JF, 1975, Systemic lupus erythematosus: a clinical analysis